Holen Sie sich die Stockscreener-App
0.9759
0.94%
-0.0093
Vorhandelsmarkt:
.96
-0.0159
-1.63%
Schlusskurs vom Vortag:
$0.9852
Offen:
$0.9613
24-Stunden-Volumen:
76,715
Relative Volume:
0.02
Marktkapitalisierung:
$18.20M
Einnahmen:
$174.80K
Nettoeinkommen (Verlust:
$-8.85M
KGV:
-1.417
EPS:
-0.6887
Netto-Cashflow:
$-4.37M
1W Leistung:
-9.64%
1M Leistung:
-29.28%
6M Leistung:
-21.30%
1J Leistung:
-76.48%
1-Tages-Spanne:
$0.9613
$0.991
1-Wochen-Bereich:
$0.91
$1.0983
52-Wochen-Spanne:
$0.702
$4.39
Nexalin Technology Inc Stock (NXL) Company Profile
Firmenname
Nexalin Technology Inc
Sektor
Branche
Telefon
(832) 260-0222
Adresse
1776 YORKTOWN, HOUSTON
Vergleichen Sie NXL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
0.9759 | 18.38M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nexalin Technology Inc Aktie (NXL) Neueste Nachrichten
Will Nexalin Technology Inc. Equity Warrant stock reach Wall Street targetsTreasury Yields & Real-Time Stock Entry Alerts - Newser
Nexalin advances Alzheimer’s device after FDA meeting By Investing.com - Investing.com South Africa
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pocono Record
Nexalin Technology completes FDA Q-submission meeting for Gen-2 Sync - marketscreener.com
Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program - Yahoo Finance
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4 - markets.businessinsider.com
How Nexalin Technology Inc. stock trades before earnings2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Nexalin Technology earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada
Volume Summary: Is Nexalin Technology Inc. Equity Warrant stock supported by strong cash flows2025 Technical Patterns & Smart Swing Trading Alerts - BỘ NỘI VỤ
Investors in cash trouble should check out Nexalin Technology Inc (NXL) - Setenews
Nexalin Technology (NASDAQ:NXL) Rating Lowered to Sell at Wall Street Zen - Defense World
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Nexalin Technology Inc. Equity Warrant stock near bottom after decline2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why hedge funds are buying Nexalin Technology Inc. stockEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
Price momentum metrics for Nexalin Technology Inc. explainedWeekly Market Report & Expert Curated Trade Setup Alerts - newser.com
Is Nexalin Technology Inc. Equity Warrant stock trading near support levelsEarnings Miss & Short-Term High Return Strategies - newser.com
Can Nexalin Technology Inc. stock withstand economic slowdown - newser.com
Trend analysis for Nexalin Technology Inc. this weekJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Risk vs reward if holding onto Nexalin Technology Inc.Buy Signal & High Accuracy Buy Signal Tips - newser.com
Is Nexalin Technology Inc. stock attractive for retirement portfoliosJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com
Will Nexalin Technology Inc. stock deliver better than expected guidanceQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
Should you wait for a breakout in Nexalin Technology Inc.Trade Risk Summary & High Accuracy Trade Alerts - newser.com
How Nexalin Technology Inc. Equity Warrant stock performs in rate cut cyclesPortfolio Performance Summary & Expert Verified Movement Alerts - newser.com
How to monitor Nexalin Technology Inc. Equity Warrant with trend dashboardsJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
How analysts rate Nexalin Technology Inc. stock today2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Will Nexalin Technology Inc. Equity Warrant stock benefit from automationJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
How to monitor Nexalin Technology Inc. with trend dashboardsIndex Update & Reliable Price Breakout Alerts - newser.com
Can Nexalin Technology Inc. stock double in next 5 years2025 Short Interest & Consistent Profit Alerts - newser.com
Can Nexalin Technology Inc. stock reach $100 price targetQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
Detecting price anomalies in Nexalin Technology Inc. Equity Warrant with AIWeekly Trend Recap & Low Risk Entry Point Guides - newser.com
Statistical indicators supporting Nexalin Technology Inc.’s strength2025 Sector Review & Weekly High Conviction Ideas - newser.com
Published on: 2025-11-19 02:41:36 - newser.com
What data driven models say about Nexalin Technology Inc.’s future2025 Volatility Report & Weekly High Return Opportunities - newser.com
Finanzdaten der Nexalin Technology Inc-Aktie (NXL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nexalin Technology Inc-Aktie (NXL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
2.89%
4.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):